JPH06197946A - Locally absorbing hemostatic material - Google Patents

Locally absorbing hemostatic material

Info

Publication number
JPH06197946A
JPH06197946A JP5292437A JP29243793A JPH06197946A JP H06197946 A JPH06197946 A JP H06197946A JP 5292437 A JP5292437 A JP 5292437A JP 29243793 A JP29243793 A JP 29243793A JP H06197946 A JPH06197946 A JP H06197946A
Authority
JP
Japan
Prior art keywords
collagen
fiber
cotton
hemostatic
hemostatic material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5292437A
Other languages
Japanese (ja)
Other versions
JP3404097B2 (en
Inventor
Yoshihiko Shimizu
慶彦 清水
Toru Natsume
徹 夏目
Toshikazu Makihara
俊和 牧原
Masanori Akasaka
昌紀 赤坂
Masanori Sakakibara
巨規 榊原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Rayon Co Ltd
NH Foods Ltd
Original Assignee
Nippon Meat Packers Inc
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Meat Packers Inc, Mitsubishi Rayon Co Ltd filed Critical Nippon Meat Packers Inc
Priority to JP29243793A priority Critical patent/JP3404097B2/en
Publication of JPH06197946A publication Critical patent/JPH06197946A/en
Application granted granted Critical
Publication of JP3404097B2 publication Critical patent/JP3404097B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a local hemostatic material made of collagen which has a sufficient blood stopping function while allowing safe and quick absorption in vivo after use and moreover, provides high operability by accomplishing a cross linking of at least a part of a collagen molecule composing a fiber by heat. CONSTITUTION:An insoluble collagen obtained from a fresh bovine skin is treated by pepsin to obtain an atherocollagen with telopeptide made soluble while being digested. This solution is dissolved into a hydrochloric acid aqueous solution to obtain an atherocollagen fiber by a wet spinning method ammonium sulfate as a coagulation liquid. The fiber is desalted and dewatered by methanol and cut to a length of 50mm after being dried to be separated by an air blowing. Then, a thermal treatment is performed at a specified temperature to obtain a cotton0like product of the collagen fiber. The length of the fiber is 3-70mm, the diameter thereof 10-70mum and a specific capacity 2-80cm<2>.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、外科領域において使用
されるコラーゲン繊維の綿状物からなる局所吸収性止血
材に関するものであって、特に、実質臓器からの出血や
毛細血管性出血に対して迅速かつ有効に適応され得る局
所吸収性止血材に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a locally absorbable hemostatic material composed of a cotton-like material of collagen fibers used in the surgical field, and particularly to bleeding from a solid organ or capillary bleeding. The present invention relates to a locally absorbable hemostatic material that can be quickly and effectively applied.

【0002】[0002]

【従来の技術】外科手術時の止血法としては、圧迫法、
結紮法、電気凝固法や、トロンビンやフィブリン糊等の
生理活性物質の応用等がある。出血点のはっきりしてい
る動脈性出血に対しては、一般に結紮法や電気凝固法が
用いられ、静脈性の出血であれば圧迫だけでも充分であ
り、止血は容易である。しかしながら、実質臓器からの
出血や毛細血管性出血に対してはこれらの止血法が無効
である場合があり、肝不全や心臓血管外科領域で出血傾
向にある場合には特に止血に困難をきたす。このような
場合、出血面に接触させるだけで血液凝固反応を促進
し、速やかに血栓を形成し出血を阻止する局所吸収性止
血材が、手術時間を短縮するのみならず術後の再出血を
も防止し、安全な術後管理にも貢献するので効果的であ
る。この目的で、酸化セルロ−スを材料とする種々の局
所止血材が開発され臨床応用されてきたが、安価であり
操作性に優れるという長所を有するものの、生体由来の
材料でないため、生体内での吸収が遅く強い溶血反応と
異物反応を惹起するという難点があり、近年は、抗原性
が低く生体に安全に吸収されるためアレルギ−反応と異
物反応を最小限にとどめ得るとして生体由来の蛋白質で
あるコラ−ゲンを用いた局所止血材が、それ自身の生理
活性作用(血小板を粘着凝集させ、凝集した血小板より
放出される血小板第III 因子により血液凝固系を促進し
血栓を形成させる作用)を有する(従って、止血効果も
高い)こともあって盛んに臨床応用されるようになっ
た。
2. Description of the Related Art As a hemostatic method during surgery, a compression method,
There are ligation method, electrocoagulation method, and application of physiologically active substances such as thrombin and fibrin glue. Ligation or electrocoagulation is generally used for arterial bleeding with a clear bleeding point, and if venous bleeding, compression is sufficient and hemostasis is easy. However, these hemostatic methods may be ineffective for bleeding from a solid organ or capillary bleeding, and hemostasis is particularly difficult when bleeding tends to occur in liver failure or cardiovascular surgery. In such a case, a locally absorbable hemostatic material that accelerates the blood coagulation reaction just by contacting the bleeding surface, quickly forms a thrombus, and prevents bleeding, not only shortens the operation time but also causes re-bleeding after surgery. It is also effective because it also contributes to safe postoperative management. For this purpose, various topical hemostatic agents using oxidized cellulose as a material have been developed and clinically applied.However, although they have the advantage of being inexpensive and excellent in operability, they are not materials of biological origin, so in vivo It has a drawback that it is slow to be absorbed and induces a strong hemolytic reaction and a foreign body reaction, and in recent years, since the allergic reaction and the foreign body reaction can be minimized because the antigenicity is low and it is safely absorbed by the body, The local hemostatic agent using collagen is its own physiologically active action (adhesion and aggregation of platelets, action of platelet factor III released from the aggregated platelets to accelerate the blood coagulation system and form thrombus). It has been widely used clinically due to the fact that it has (and therefore has a high hemostatic effect).

【0003】現在実用化されているコラーゲン製の局所
止血材には、コラ−ゲンの微細繊維をフレーク状にした
ものやコラ−ゲンスポンジを平板状にしたものがある
が、前者については、コラ−ゲンの抗原性決定基である
テロペプタイドが残存しているため生体内で抗原性を示
すので使用後に取り除く必要があるとともにフレーク状
であるが故に血液に流され飛び散るため止血効果があま
り期待できないし、静電気を帯びやすく使用の際に手や
ピンセットに付着しやすいという操作面での難点があ
り、一方、後者については、テロペプタイドを取り除い
たアテロコラ−ゲンからなるものもあるが、平板状であ
ることから複雑な形状の創面に対する密着性が充分でな
く、圧迫止血もできなくなるので、前者と同様止血効果
があまり期待できない。
A collagen-made topical that is currently in practical use
As a hemostatic material, fine particles of collagen were made into flakes.
There is a flat plate type of thing or collagen sponge
However, for the former, it is an antigenic determinant of collagen.
Shows antigenicity in vivo due to residual telopeptides
It must be removed after use and is flaky.
Therefore, it has a hemostatic effect because it is washed away by blood and scatters.
You can not expect it, and it is easy to be charged with static electricity,
There is a difficulty in operation that it easily adheres to the tweezers.
On the other hand, for the latter, remove the telopeptide
Some are made of atherocollagen, but are flat.
Therefore, the adhesion to the wound surface with a complicated shape is not sufficient.
In addition, it is not possible to stop pressure bleeding.
Can't expect much.

【0004】前記の欠点を改善するものとして、アテロ
コラ−ゲンからなる綿状の局所止血材が発表されてい
る。例えば、豚皮由来のアテロコラ−ゲンを紡糸し乾燥
して綿状にしたもの(清水他、人工臓器19(3)、1
235(1990))や、紡糸したコラ−ゲンを架橋剤
により処理した後、洗浄、凍結乾燥して綿状にすると共
に表面に微細なひび割れ状の亀裂を生じさせたもの(特
開平4−61862号公報)等があるが、前者は、可溶
性であるアテロコラ−ゲンをそのまま使用していること
から止血に用いた場合、血液を吸収して繊維の強度が著
しく低下し血流を阻止することが困難なため充分な止血
効果が期待できない。一方、後者では、凍結乾燥に先立
ち架橋剤による架橋処理をしていることからコラ−ゲン
の持つ止血作用が損なわれてしまうし、安全性の面から
未反応架橋剤を完全に除去するための洗浄操作を必要と
するなどの問題点があった。
As a solution to the above-mentioned drawbacks, a cotton-like local hemostatic material comprising atelocollagen has been announced. For example, pig-skin-derived atelocollagen is spun and dried into a cotton shape (Shimizu et al., Artificial organ 19 (3), 1
235 (1990)) or spun collagen treated with a cross-linking agent, washed and freeze-dried to give a cotton-like shape and fine cracks on the surface (Japanese Patent Laid-Open No. 4-61862). However, the former uses soluble atelocollagen as it is, and therefore, when used for hemostasis, it may absorb blood and significantly reduce the strength of the fiber to block blood flow. It is difficult to expect a sufficient hemostatic effect. On the other hand, in the latter, the hemostatic action of collagen is impaired because the crosslinking treatment with a crosslinking agent is performed prior to freeze-drying, and in order to completely remove the unreacted crosslinking agent from the viewpoint of safety. There was a problem that a cleaning operation was required.

【0005】[0005]

【発明が解決しようとする課題】本発明は、上記従来の
コラーゲン製止血材の課題を解決する止血材を提供す
る、すなわち充分な止血能を有するとともに使用後に生
体内で安全かつ速やかに分解吸収され、しかも操作性の
よいコラーゲン製局所止血材を提供することを目的とし
ている。
DISCLOSURE OF THE INVENTION The present invention provides a hemostatic material that solves the above-mentioned problems of the conventional collagen hemostatic material, that is, it has a sufficient hemostatic ability and is decomposed and absorbed safely in vivo after use. It is an object of the present invention to provide a collagen local hemostatic material which has excellent operability.

【0006】[0006]

【課題を解決するための手段】かかる目的のため検討を
重ねた結果、本発明に到達した。すなわち、本発明は、
可溶化コラーゲンを再生したアテロコラーゲンの繊維か
らなる綿状物であって、該繊維の直径が10〜70μ
m、繊維の長さが3〜70mmであり、それを構成する
コラ−ゲン分子の少なくとも一部を熱により架橋させた
ものであることを特徴とする。
As a result of repeated studies for such purpose, the present invention has been achieved. That is, the present invention is
A cotton-like material composed of atelocollagen fibers regenerated from solubilized collagen, the diameter of the fibers being 10 to 70 μm.
m, the length of the fiber is 3 to 70 mm, and at least a part of the collagen molecule constituting the fiber is crosslinked by heat.

【0007】本発明において可溶化コラ−ゲンとは、蛋
白質分解酵素による可溶化処理、あるいはアルカリによ
る可溶化処理を行い、可溶化と同時にコラ−ゲンの抗原
決定基であるテロペプタイドの除去操作を施したコラ−
ゲンのことである。本発明の原料として使用されるコラ
−ゲンの由来は特に限定されないが、一般には、哺乳動
物(例えば、ヒト、ウシ、ブタ、ウサギ、ヒツジ、ネズ
ミ等)の皮膚、骨、軟骨、腱、臓器などから得られるコ
ラ−ゲンを用いる。また、鳥類、魚類などから得たコラ
−ゲン様蛋白質を用いることもできる。
In the present invention, the solubilized collagen is a solubilization treatment with a proteolytic enzyme or an alkali solubilization treatment, and at the same time as the solubilization, an operation for removing telopeptide which is an antigenic determinant of collagen is performed. The applied color
It is Gen. The origin of the collagen used as the raw material of the present invention is not particularly limited, but generally, the skin, bone, cartilage, tendon, organ of mammals (for example, human, bovine, porcine, rabbit, sheep, rat etc.) Collagen obtained from, for example, is used. Also, a collagen-like protein obtained from birds, fish and the like can be used.

【0008】一般的に、蛋白質分解酵素による可溶化処
理を行ったコラ−ゲンは、アルカリによる可溶化処理を
行ったものに比べ血小板に対する活性が高いため蛋白質
分解酵素による可溶化処理を行ったコラ−ゲンを用いる
ことが好ましい。
In general, collagen which has been solubilized with a proteolytic enzyme has a higher activity on platelets than that which has been solubilized with an alkali, and therefore collagen which has been solubilized with a proteolytic enzyme is used. -Preference is given to using gen.

【0009】コラーゲン止血材による止血は、先ず湧出
する血液が物理的に抑止され、次いでコラーゲン自身の
止血作用が発揮されることによってなされるので、充分
な止血効果を発揮させるためには止血材を構成する繊維
の強度が重要な因子となる。繊維の強度は、構成繊維の
直径が太いほうが大きくなるが、あまり太いものでは繊
維が剛直化してしまい形状加工しにくくなるため、10
〜70μmがよく、好ましくは15〜45μmである。
Hemostasis by a collagen hemostatic material is performed by physically suppressing the blood that springs out first and then exerting the hemostatic action of collagen itself. Therefore, in order to exert a sufficient hemostatic effect, a hemostatic material should be used. The strength of the constituent fibers is an important factor. Regarding the strength of the fiber, the thicker the diameter of the constituent fiber is, the larger the diameter of the constituent fiber becomes.
˜70 μm is preferable, and 15 to 45 μm is preferable.

【0010】繊維の長さは、該繊維が可溶性コラーゲン
を再生することによって得られるため任意の長さのもの
を得ることができるが、あまり長いものでは綿状にする
際に充分分散させることが難しくなり、短すぎると繊維
同士が絡みにくく止血材の適用の際に散らばってしまう
し血圧に抗する強度も得られなくなるため、3〜70m
mがよく、好ましくは、5〜50mmである。
Regarding the length of the fiber, it can be obtained by regenerating soluble collagen so that the fiber can be of any length, but if it is too long, it can be dispersed sufficiently when it is made into a cotton shape. If the length is too short, the fibers will not easily get entangled with each other, and the fibers will be scattered when the hemostatic material is applied, and the strength against blood pressure cannot be obtained.
m is good, and preferably 5 to 50 mm.

【0011】本発明の局所吸収性止血材は、血液を含む
と膨潤し全体の容積が増加する。その結果、適用部位周
囲組織への圧迫止血効果を発現する。その圧迫止血効果
は、止血材にある程度の強度があってこそ発現される。
可溶化コラ−ゲンから得られた繊維はその膨潤の程度が
著しく、膨潤にともない強度が低下するため、本発明で
は該繊維を構成するコラ−ゲン分子の少なくとも1部を
熱により架橋することにより、コラ−ゲンが本来有する
止血作用を保持させつつ、止血材としての適度な膨潤性
(該繊維は、緻密な表面構造を有しているが、血液をす
みやかに吸収して体積膨張を起こし、出血部位に対する
圧迫止血効果をもたらす)と強度(血流を完全に阻止し
て早期に止血を達成させる作用)を付与させることにし
た。
The locally absorbable hemostatic material of the present invention swells when it contains blood, and the whole volume increases. As a result, a compression and hemostatic effect is exerted on the tissue surrounding the application site. The compressive hemostatic effect is exhibited only when the hemostatic material has some strength.
The fiber obtained from the solubilized collagen has a significant degree of swelling, and the strength decreases with the swelling. Therefore, in the present invention, at least a part of the collagen molecules constituting the fiber is crosslinked by heat. , While maintaining the hemostatic action originally possessed by collagen, moderate swelling properties as a hemostatic material (the fiber has a dense surface structure, but immediately absorbs blood to cause volume expansion, We decided to give it strength (the effect of completely blocking the blood flow and achieving hemostasis early), which brings about a pressure hemostatic effect on the bleeding site.

【0012】従来、コラ−ゲンを架橋する場合アルデヒ
ド類、ジエポキシド類等の架橋剤を用いる方法が用いら
れているが、架橋剤にて処理されたコラ−ゲンでは、コ
ラ−ゲンの血小板に対する活性が失われてしまうため止
血能の向上が期待できない(熱処理では、コラ−ゲンの
血小板に対する反応性が失活しにくい)。また、架橋剤
を用いる方法は、止血材として適当な膨潤度を残した架
橋の程度で反応を止めることができないし、用いられる
架橋剤は毒性を持つことが多いことから未反応の架橋剤
の除去のための洗浄操作が必要とされるなど問題点が多
い。
Conventionally, a method using a cross-linking agent such as aldehydes and diepoxides has been used in the case of cross-linking collagen. However, in the case of collagen treated with the cross-linking agent, the activity of collagen on platelets is high. Therefore, improvement of hemostatic ability cannot be expected (the heat treatment does not easily inactivate the reactivity of collagen with platelets). In addition, the method using a cross-linking agent cannot stop the reaction by the degree of cross-linking that leaves an appropriate degree of swelling as a hemostatic agent, and since the cross-linking agent used is often toxic, unreacted There are many problems such as a cleaning operation for removal.

【0013】熱による架橋処理は、50〜200℃の範
囲で行うのがよい。50℃より低いと架橋が不充分又は
架橋が行われなくなってしまうし、一方、200℃を越
えるとコラ−ゲンの変性が顕著であり膨潤性と生理活性
作用が損なわれてしまうからである。製造と品質の両要
因を考慮すると、更に好ましくは60〜180℃、特に
好ましくは、95〜150℃である。
The thermal crosslinking treatment is preferably carried out in the range of 50 to 200 ° C. If the temperature is lower than 50 ° C, the crosslinking will be insufficient or the crosslinking will not be performed. On the other hand, if the temperature is higher than 200 ° C, the collagen is remarkably denatured and the swelling property and the physiological activity are impaired. Considering both manufacturing and quality factors, the temperature is more preferably 60 to 180 ° C, and particularly preferably 95 to 150 ° C.

【0014】局所吸収性止血材として有すべきその他の
物理的特性としては、止血材の取扱性と創傷部位への密
着性という点において、コラーゲン繊維の綿状物の比容
積も重要である。繊維の比容積は、適用の際の形状加工
のしやすさ(さまざまな形状をした創傷部位に合わせて
止血材の形を変え、均一に密着させることにより止血効
果を最大限に発揮させることができる)からは高いほう
が良いが、繊維同士が適度に絡み合うためにはおのずと
その限界があるし、あまり高いと繊維が飛散したり適用
の際に隙間ができてしまい完全に止血することが困難に
なるため、20〜80cm3 /gがよく、好ましくは4
0〜70cm3 /g程度である。
As another physical property that should be possessed as the locally absorbable hemostatic material, the specific volume of the cotton-like material of collagen fiber is also important in terms of handleability of the hemostatic material and adhesion to the wound site. The specific volume of the fiber is easy to shape when applied (the hemostatic effect can be maximized by changing the shape of the hemostatic material according to the wound site with various shapes and evenly adhering it. It is better to be able to do so), but there is a limit to the fact that the fibers can be properly entangled with each other, and if it is too high, it will be difficult to completely stop hemostasis because the fibers will scatter and gaps will be created during application. Therefore, 20 to 80 cm 3 / g is preferable, and 4 is preferable.
It is about 0 to 70 cm 3 / g.

【0015】ここで、比容積は、次のようにして求めた
ものである(以下、コラーゲン繊維の綿状物を基準とし
て記載したが、フレ−ク状物も同様にして計測する)。 得られたコラーゲン繊維の綿状物を標準状態(20
℃,65%RH)下で約1gを採り、正確に秤量する
(計測重量:Wg)。 標準状態下で、内径35mmの透明なプラスチック
円筒内に均一に充填する。 次に、直径30mm,重さ5.0gの平円板を、
で準備された綿状物の上に乗せ、更にその上に50gの
分銅を30秒間載せた後該分銅を取り除き30秒間放置
する。この操作を3回繰り返し、次いで充填された綿状
物の高さを周方向3ヶ所にて計測する(平均値をHmm
とする)。 次式に従って比容積をサンプル3個について求め、
その平均値を採用する。 比容積(cm3 /g)=((35/20)2 ×π×H/
10)/W
Here, the specific volume is determined as follows (hereinafter, the cotton-like material of collagen fiber is described as a reference, but the flaky material is also measured in the same manner). The obtained cotton-like material of collagen fibers was put in a standard state (20
Approximately 1 g is taken under (° C, 65% RH) and accurately weighed (measured weight: Wg). Under standard conditions, it is uniformly filled in a transparent plastic cylinder with an inner diameter of 35 mm. Next, a flat disk with a diameter of 30 mm and a weight of 5.0 g
It is placed on the cotton-like material prepared in step 1, and a weight of 50 g is placed on the cotton-like material for 30 seconds, and then the weight is removed and left for 30 seconds. This operation is repeated 3 times, and then the height of the filled cotton-like material is measured at 3 locations in the circumferential direction (the average value is Hmm.
And). The specific volume was calculated for three samples according to the following formula,
The average value is adopted. Specific volume (cm 3 / g) = ((35/20) 2 × π × H /
10) / W

【0016】[0016]

【実施例】【Example】

実施例1 新鮮牛皮より得られた不溶性コラーゲンを、蛋白質分解
酵素(ペプシン。以下同様)によって処理してテロペプ
タイドを消化すると共に可溶化したアテロコラーゲンの
溶液を得た。つぎにこれをpH2に調製した塩酸水溶液
に溶解(コラーゲン濃度:6%)し、20%硫酸アンモ
ニウムを凝固液とする湿式紡糸法にてアテロコラーゲン
繊維を得た。得られたアテロコラーゲン繊維を、メタノ
−ルにて脱塩、脱水し、乾燥した後、長さ50mmに切
断し、エアーブロー(30m/sの風速で10分間)に
より繊維を分散させ、次いで105℃で熱処理(3時
間)を行いコラーゲン繊維の綿状物を得た。得られた綿
状物の物性値は、繊維長:5〜50mm,繊維直径:1
5〜45μm,比容積:60cm3 /gであった。尚、
得られた綿状物の繊維表面の形状は図1及び図2(日本
電子(株)製走査型電子顕微鏡:JSM−840A型に
よる観察結果である)に示す通りであった。
Example 1 Insoluble collagen obtained from fresh cowhide was treated with a proteolytic enzyme (pepsin; the same applies below) to digest telopeptide and obtain a solubilized atelocollagen solution. Next, this was dissolved in a hydrochloric acid aqueous solution adjusted to pH 2 (collagen concentration: 6%), and an atelocollagen fiber was obtained by a wet spinning method using 20% ammonium sulfate as a coagulating liquid. The obtained atelocollagen fiber is desalted with methanol, dehydrated, dried and cut into a length of 50 mm, and the fiber is dispersed by air blow (10 minutes at a wind speed of 30 m / s), and then 105 ° C. Heat treatment (3 hours) was performed to obtain a cotton-like material of collagen fibers. The physical properties of the obtained cotton-like material are as follows: fiber length: 5 to 50 mm, fiber diameter: 1
It was 5 to 45 μm and the specific volume was 60 cm 3 / g. still,
The shape of the fiber surface of the obtained cotton-like material was as shown in FIG. 1 and FIG. 2 (observation result by scanning electron microscope: JSM-840A type manufactured by JEOL Ltd.).

【0017】実施例2 熱処理温度を60℃(24時間)としたこと以外、実施
例1と同様にしてコラーゲン繊維の綿状物を得た。得ら
れた綿状物の物性値は、実施例1と同じであった。
Example 2 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the heat treatment temperature was 60 ° C. (24 hours). The physical properties of the obtained cotton-like material were the same as in Example 1.

【0018】実施例3 熱処理を180℃(10分)としたこと以外、実施例1
と同様にしてコラーゲン繊維の綿状物を得た。得られた
綿状物の物性値は、実施例1と同じであった。
Example 3 Example 1 was repeated except that the heat treatment was performed at 180 ° C. (10 minutes).
A cotton-like material of collagen fibers was obtained in the same manner as in. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0019】実施例4 エアーブローによる繊維の分散処理を行わなかったこと
以外、実施例1と同様にしてコラーゲン繊維の綿状物を
得た。得られた綿状物の物性値は、繊維長:30〜50
mm,繊維直径:15〜45μm,比容積:28cm3
/gであった。
Example 4 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the fiber was not dispersed by air blowing. The physical properties of the obtained cotton-like material are as follows: fiber length: 30-50
mm, fiber diameter: 15 to 45 μm, specific volume: 28 cm 3
/ G.

【0020】実施例5 エアーブローによる繊維の分散処理の条件を40m/s
の風速で60分間としたこと以外、実施例1と同様にし
てコラーゲン繊維の綿状物を得た。得られた綿状物の物
性値は、繊維長:5〜50mm,繊維直径:15〜45
μm,比容積:78cm3 /gであった。
Example 5 The conditions for fiber dispersion treatment by air blowing were 40 m / s.
A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the wind speed was changed to 60 minutes. The physical properties of the obtained cotton-like material are as follows: fiber length: 5 to 50 mm, fiber diameter: 15 to 45
μm, specific volume: 78 cm 3 / g.

【0021】実施例6 不溶性コラ−ゲンの酵素処理に代えてアルカリ可溶化処
理(硫酸ナトリウムと水酸化ナトリウムとモノメチルア
ミンの混合溶液を使用)を行ったこと以外、実施例1と
同様にしてコラーゲン繊維の綿状物を得た。得られた綿
状物の物性値は、実施例1と同じであった。
Example 6 Collagen was prepared in the same manner as in Example 1 except that alkali solubilization treatment (using a mixed solution of sodium sulfate, sodium hydroxide and monomethylamine) was carried out in place of the enzyme treatment of insoluble collagen. A fibrous material was obtained. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0022】実施例7 新鮮牛皮に代え新鮮豚皮を使用した以外、実施例1と同
様にしてコラーゲン繊維の綿状物を得た。得られた綿状
物の物性値は、実施例1と同じであった。
Example 7 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that fresh pig skin was used instead of fresh cowhide. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0023】比較例1 熱処理を行わなかったこと以外、実施例1と同様にして
コラーゲン繊維の綿状物を得た。得られた綿状物の物性
値は、実施例1と同じであった。
Comparative Example 1 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that heat treatment was not performed. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0024】比較例2 不溶性コラ−ゲンの酵素処理に代えてアルカリ可溶化処
理(硫酸ナトリウムと水酸化ナトリウムとモノメチルア
ミンの混合溶液を使用)を行ったこと及び熱処理を行わ
なかったこと以外、実施例1と同様にしてコラーゲン繊
維の綿状物を得た。得られた綿状物の物性値は、実施例
1と同じであった。
Comparative Example 2 Except that an alkali solubilization treatment (using a mixed solution of sodium sulfate, sodium hydroxide and monomethylamine) was carried out in place of the enzyme treatment of insoluble collagen, and no heat treatment was carried out. A cotton-like material of collagen fibers was obtained in the same manner as in Example 1. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0025】比較例3 熱処理に代えてグルタ−ル・アルデヒドにて処理したこ
と以外、実施例1と同様にしてコラーゲン繊維の綿状物
を得た。得られた綿状物の物性値は、実施例1と同じで
あった。
Comparative Example 3 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the treatment was performed with glutaric aldehyde instead of the heat treatment. The physical properties of the obtained cotton-like material were the same as in Example 1.

【0026】比較例4 紡糸条件を変えたこと以外、実施例1と同様にしてコラ
ーゲン繊維の綿状物を得た。得られた綿状物の物性は、
繊維長:5〜50mm,繊維直径:7〜9μm,比容
積:65cm3 /gであった。
Comparative Example 4 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the spinning conditions were changed. The physical properties of the obtained cotton-like material are
The fiber length was 5 to 50 mm, the fiber diameter was 7 to 9 μm, and the specific volume was 65 cm 3 / g.

【0027】比較例5 紡糸条件を変えたこと以外、実施例1と同様にしてコラ
ーゲン繊維の綿状物を得た。得られた綿状物の物性は、
繊維長:5〜50mm,繊維直径:80〜100μm,
比容積:35cm3 /gであった。
Comparative Example 5 A cotton-like material of collagen fibers was obtained in the same manner as in Example 1 except that the spinning conditions were changed. The physical properties of the obtained cotton-like material are
Fiber length: 5 to 50 mm, fiber diameter: 80 to 100 μm,
Specific volume: 35 cm 3 / g.

【0028】比較例6 乾燥後の切断を長さ3mmにしたこと以外、実施例1と
同様にしてコラーゲン繊維のフレ−ク状物を得た。得ら
れたフレ−ク状物の物性値は、繊維長:0.5〜1m
m,繊維直径:15〜45μm,比容積:18cm3
gであった。
Comparative Example 6 A flaky collagen fiber material was obtained in the same manner as in Example 1 except that the length after cutting was set to 3 mm. The physical properties of the obtained flaky product are as follows: fiber length: 0.5 to 1 m
m, fiber diameter: 15 to 45 μm, specific volume: 18 cm 3 /
It was g.

【0029】比較例7 新鮮牛皮より得られた不溶性コラーゲンを、蛋白質分解
酵素によって処理してテロペプタイドを消化すると共に
可溶化したアテロコラーゲンの溶液を得た。つぎにこれ
をpH2に調整した塩酸水溶液に溶解(コラ−ゲン濃
度:3%)し、飽和硫酸ナトリウムを凝固液とする湿式
紡糸法にてコラーゲン繊維を得た。次にこれを、グルタ
−ルアルデヒド溶液にて処理した後、水洗し、無機塩及
び未反応のグルタルアルデヒドを除去した。次に、繊維
を長さ50mmに切断し、凍結乾燥してコラーゲン繊維
の綿状物を得た。得られた綿状物の物性は、繊維長:4
0〜50mm,繊維直径:10〜30μm,比容積:1
7cm3 /gであった。
Comparative Example 7 Insoluble collagen obtained from fresh cowhide was treated with a proteolytic enzyme to digest telopeptide and a solubilized atelocollagen solution was obtained. Next, this was dissolved in a hydrochloric acid aqueous solution adjusted to pH 2 (collagen concentration: 3%), and collagen fibers were obtained by a wet spinning method using saturated sodium sulfate as a coagulating liquid. Next, this was treated with a glutaraldehyde solution and then washed with water to remove inorganic salts and unreacted glutaraldehyde. Next, the fiber was cut into a length of 50 mm and freeze-dried to obtain a cotton fiber of collagen fiber. The physical properties of the obtained cotton-like material are as follows: fiber length: 4
0 to 50 mm, fiber diameter: 10 to 30 μm, specific volume: 1
It was 7 cm 3 / g.

【0030】[0030]

【発明の効果】実験開始前にヘパリンを100u/kg
全身性に投与した雑種成犬を全身麻酔下に開腹し、脾臓
の皮膜のみを1cm×1cmの大きさに正確にメスで剥離す
る。次に、上記の各実施例及び比較例にて得られたコラ
ーゲン綿状物及びフレ−ク状物各0.1gを前記剥離面
に当て30秒間圧迫した後、出血量を1分間隔で計測し
た(1分間乾燥したガ−ゼを出血面に当て、その際にガ
−ゼに吸い取られた血液によって描かれるサ−クルの半
径をもって出血量とした。以下、この指標をBleeding D
egree:BDという。BDの初期値をBDt=0 ,経過時間ごとの
BDをBDt=t とし、次式に従って求めた値を止血率:HRと
する。尚、ガ−ゼにまったく血液がしみ込まない状態を
もって止血の完了とした)。 HR(%)=(1−(BDt=t /BDt=0 ))×100 各10例を施行したときのデ−タを表1に示す。該表に
は、上記の各実施例及び比較例にて得られたコラ−ゲン
綿状物及びフレ−ク状物0.1gを剥離面の形状に合わ
せ加工し、そして剥離面に適用するまでに要する時間
(再加工時間という)の測定結果を併せ示した。
[Effect of the invention] Heparin is added at 100 u / kg before the start of the experiment.
A systemically-administered mixed-breed dog is opened under general anesthesia, and only the spleen capsule is exactly peeled off with a scalpel to a size of 1 cm x 1 cm. Next, 0.1 g of each of the collagen cotton-like material and the flaky material obtained in each of the above Examples and Comparative Examples was applied to the release surface and pressed for 30 seconds, and then the blood loss was measured at 1-minute intervals. (The gauze dried for 1 minute was applied to the bleeding surface, and the radius of the circle drawn by the blood sucked by the gauze at that time was defined as the bleeding amount. Hereinafter, this index is referred to as Bleeding D
egree: BD. The initial value of BD is BD t = 0 ,
BD is BD t = t, and the value obtained according to the following equation is the hemostasis rate: HR. In addition, hemostasis was completed when the blood did not soak into the gase). HR (%) = (1− (BD t = t / BD t = 0 )) × 100 The data obtained when 10 cases were applied are shown in Table 1. In the table, 0.1 g of the collagen cotton-like material and the flaky material obtained in each of the above Examples and Comparative Examples was processed according to the shape of the release surface, and applied to the release surface. The results of measurement of the time required for (reprocessing time) are also shown.

【0031】[0031]

【表1】 [Table 1]

【0032】結果から、本発明による止血用コラーゲン
綿状物は、止血能及び取り扱い性ともに優れていること
が明らかである(本実験において、止血の初期(2分後
まで)に止血が完了しなかった実験例では滲出する血液
が部分的に止血材を押し分けて(止血材を構成する繊維
が血圧に抗するだけの強度を保てないため)あふれ出す
ため止血が困難になった。すなわち、2分後までに止血
が完了していることがきわめて重要である)。
From the results, it is clear that the hemostatic collagen cotton-like material according to the present invention is excellent in both hemostatic ability and handleability (in this experiment, hemostasis was completed at the initial stage (up to 2 minutes) of hemostasis). In the non-experimental example, the exuding blood partly pushed the hemostatic material away (because the fibers constituting the hemostatic material cannot maintain the strength enough to withstand the blood pressure), and thus hemostasis became difficult. It is extremely important that hemostasis is completed by 2 minutes).

【0033】本発明によるコラーゲン繊維の綿状物は、
可溶化コラーゲンを再生することにより得られる適当な
長さと比容積を持つ繊維集合体であり、該繊維を構成す
るコラ−ゲン分子の少なくとも1部を熱架橋したので、
止血の第1段階である出血液に対する抑止効果が向上
し、コラ−ゲン本来の止血作用を損なうことなく充分な
止血能を発揮する。しかも、適当な比容積を持つことか
ら、出血部位の形状に合わせて容易に加工でき、止血に
際して迅速に使用することができると共に、出血面に対
する密着性が良く止血効果が高い。
The cotton-like material of collagen fiber according to the present invention is
It is a fiber aggregate having an appropriate length and specific volume obtained by regenerating solubilized collagen, and at least a part of collagen molecules constituting the fiber is thermally crosslinked,
The effect of suppressing hemorrhage, which is the first step of hemostasis, is improved, and sufficient hemostatic ability is exhibited without impairing the original hemostatic action of collagen. Moreover, since it has an appropriate specific volume, it can be easily processed according to the shape of the bleeding site, can be used quickly for hemostasis, and has good adhesion to the bleeding surface and a high hemostasis effect.

【図面の簡単な説明】[Brief description of drawings]

第1図は、本発明の局所吸収性止血材を構成するアテロ
コラ−ゲン繊維表面の形状を示す顕微鏡写真(倍率:1
000倍)である。第2図は、該表面を更に拡大した顕
微鏡写真(倍率:7000倍)である。
FIG. 1 is a micrograph showing the shape of the surface of the atelocollagen fiber constituting the locally absorbable hemostatic material of the present invention (magnification: 1
000 times). FIG. 2 is a micrograph (magnification: 7,000 times) of the surface further enlarged.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 夏目 徹 茨城県つくば市緑ケ原3丁目3番 日本ハ ム株式会社中央研究所内 (72)発明者 牧原 俊和 茨城県つくば市緑ケ原3丁目3番 日本ハ ム株式会社中央研究所内 (72)発明者 赤坂 昌紀 愛知県名古屋市東区砂田橋四丁目1番60号 三菱レイヨン株式会社商品開発研究所内 (72)発明者 榊原 巨規 東京都中央区京橋二丁目3番19号 三菱レ イヨン株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Toru Natsume Toru Natsume 3-3 Midorigahara, Tsukuba-shi, Ibaraki Central Research Institute, Nippon Ham Co., Ltd. (72) Toshikazu Makihara 3-3 Midorigahara, Tsukuba, Ibaraki Japan Ham Central Research Institute, Inc. (72) Inventor Masanori Akasaka 4-chome, Sunadabashi, Higashi-ku, Aichi Prefecture Mitsubishi Rayon Co., Ltd. Product Development Laboratory (72) Inventor, Keiki Sakakibara 2-3-19 Kyobashi, Chuo-ku, Tokyo Within Mitsubishi Rayon Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 可溶化コラーゲンを再生したアテロコラ
ーゲンの繊維からなる綿状物であって、該コラーゲン繊
維の直径が10〜70μm、繊維の長さが3〜70mm
であり、該繊維を構成するコラーゲン分子の少なくとも
1部を熱により架橋させたものであることを特徴とする
局所吸収性止血材。
1. A cotton-like material comprising atelocollagen fibers regenerated from solubilized collagen, wherein the collagen fibers have a diameter of 10 to 70 μm and a fiber length of 3 to 70 mm.
A locally absorbable hemostatic material characterized in that at least a part of collagen molecules constituting the fiber is crosslinked by heat.
【請求項2】 熱による架橋が、50〜200℃にて行
われたものである請求項1に記載の局所吸収性止血材。
2. The locally absorbable hemostatic material according to claim 1, wherein crosslinking by heat is carried out at 50 to 200 ° C.
【請求項3】 綿状物の比容積が、20〜80cm3
gである請求項1又は2に記載の局所吸収性止血材。
3. The specific volume of the cotton-like material is 20 to 80 cm 3 /
The locally absorbable hemostatic material according to claim 1 or 2, which is g.
JP29243793A 1992-11-02 1993-10-29 Locally absorbable hemostat Expired - Lifetime JP3404097B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29243793A JP3404097B2 (en) 1992-11-02 1993-10-29 Locally absorbable hemostat

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4-294273 1992-11-02
JP29427392 1992-11-02
JP29243793A JP3404097B2 (en) 1992-11-02 1993-10-29 Locally absorbable hemostat

Publications (2)

Publication Number Publication Date
JPH06197946A true JPH06197946A (en) 1994-07-19
JP3404097B2 JP3404097B2 (en) 2003-05-06

Family

ID=26558987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29243793A Expired - Lifetime JP3404097B2 (en) 1992-11-02 1993-10-29 Locally absorbable hemostat

Country Status (1)

Country Link
JP (1) JP3404097B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009175A1 (en) * 1998-08-14 2000-02-24 Tapic International Co., Ltd. Topically absorbent hemostatic material

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009175A1 (en) * 1998-08-14 2000-02-24 Tapic International Co., Ltd. Topically absorbent hemostatic material

Also Published As

Publication number Publication date
JP3404097B2 (en) 2003-05-06

Similar Documents

Publication Publication Date Title
US5837278A (en) Resorbable collagen membrane for use in guided tissue regeneration
Chvapil Considerations on manufacturing principles of a synthetic burn dressing: a review
US3742955A (en) Fibrous collagen derived product having hemostatic and wound binding properties
JP4104462B2 (en) Method for preparing collagen sponge, apparatus for extracting part of collagen foam, and elongated collagen sponge
US4749689A (en) Hemostatic agent composed of collagen/gelatin and protamine
US4148664A (en) Preparation of fibrous collagen product having hemostatic and wound sealing properties
KR20010052714A (en) Collagen Material and Process for Producing the Same
US4074713A (en) Poly(N-acetyl-D-glucosamine) products
US5679372A (en) Absorbable topical hemostat
JPH1066723A (en) Bio-absorbing medical device formed with oxidized polysaccharide
CA2129498A1 (en) Material for medical use and process for preparing same
JPH08294530A (en) Cardiovascular restoration material and its production
JP4968976B2 (en) Collagen material and production method thereof
JP3726280B2 (en) Medical collagen membrane
JPH0461862A (en) Collagen fiber hemostatic material and its manufacture
JPH0835193A (en) Production of collagen fiber nonwoven fabric sheet
WO1998022156A1 (en) Artificial esophagus
TW434001B (en) Styptic material for local absorption
JPS6330023B2 (en)
JP3404097B2 (en) Locally absorbable hemostat
JPH08196614A (en) Locally absorptive hemostatic agent
JP2002143210A (en) Absorbent covering-protecting material for wound using cellulose sponge, and its manufacturing method
JPH06296673A (en) Fiber for hemostatic material
JP2010029684A (en) Collagen material and process for producing the same
Kato Development of a reconstituted collagen fiber tendon/ligament prosthesis: Experimental studies in rabbits

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080229

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090228

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100228

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110228

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120229

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130228

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140228

Year of fee payment: 11

EXPY Cancellation because of completion of term